Navigation Links
Dialysis Catheter Placement Makes Little Difference in Infection Risk
Date:5/27/2008

Neck, leg sites similar, but jugular should be choice for patients with higher BMI

TUESDAY, May 27 (HealthDay News) -- There's little overall difference in infection risk if a catheter for dialysis is inserted into a neck vein or an upper leg vein in critically ill patients, French researchers report.

Currently, it's widely believed the neck catheter is less likely to cause infection than the leg catheter.

The researchers compared rates of bacteria growth on catheters (catheter colonization) at the time of their removal and rates of catheter-related blood stream infections among 750 severely ill patients in intensive care units who required catheter insertion for dialysis. The patients were randomly selected to have the catheter inserted in the neck (jugular) vein or the leg (femoral) vein.

Catheter colonization occurred at a rate of 40.8 per 1,000 catheter-days among patients in the femoral group and a rate of 35.7 per 1,000 catheter-days among those in the jugular group. Catheter-related bloodstream infection occurred in three of 324 (0.9 percent) of patients in the femoral group and in five of 313 (1.6) percent of patients in the jugular group. This was not a statistically significant difference.

The study authors said the findings are "inconsistent with the widely accepted convention to avoid femoral catheterization to prevent the risk of catheter-related infection."

They did find that hematoma formation (localized area of bleeding beneath the skin) was significantly higher in the jugular group (3.6 percent) than in the femoral group (1.1 percent).

The researchers also found that people with a body-mass index (BMI) of less than 24.2 had twice the risk of catheter colonization when given a jugular catheter than when given a femoral catheter. But patients with a BMI greater than 28.4 were 60 percent less likely to develop catheter colonization when given a jugular catheter than when given a femoral catheter.

"In conclusion, the decision for the best site of insertion to prevent complications might be more complex than previously suggested. Our results support the current guideline for preventing catheter complications regarding the optimal site for catheter insertion in the ICU. If a subclavian approach is not available, and the individual risk of complications between the jugular and femoral sites is equal, the jugular site should be strongly considered for patients with higher BMI. We suggest that first-choice careful femoral catheterization by an experienced operator with full sterile precautions and appropriate post-insertion site care in non-obese, bed-bound, severely ill patients is acceptable and could reduce catheter-related morbidity compared with jugular catheterization," the researchers wrote.

The study is published in the May 28 issue of the Journal of the American Medical Association.

More information

The National Kidney Foundation has more about dialysis catheters.



-- Robert Preidt



SOURCE: Journal of the American Medical Association, news release, May 27, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Reducing blockage fails to improve access to the bloodstream for kidney dialysis
2. More intensive dialysis does not improve outcomes among patients with acute kidney injury
3. Endovascular Forum and CiDA Collaborate to Launch a Collective Intelligence Instrument for Dialysis Access Physicians
4. More Dialysis Not Better in Acute Kidney Injury
5. Blood-Thinner No Help for Dialysis Treatment
6. Kidney Community Gathers on Capitol Hill to Ask Congress to Support Legislation for Increased Kidney Care Education, Updates for Kidney Dialysis Benefit
7. Dialysis Corporation of America Announces the Development of a New Facility in Pennsylvania
8. Dialysis Corporation of America Earnings Call Reminder
9. Dialysis Corporation of America Reports Fourth Quarter and Year Ended December 31, 2007 Results
10. Dialysis Corporation of America Announces Fiscal Year 2007 Earnings Release Date
11. Dialysis Corporation of America Announces its Newest Center Opening in South Carolina
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their media with ... X," said Christina Austin - CEO of Pixel Film Studios. , ProSlice Color ... users can now reveal the media of their split screens with growing colorful ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... patient payment industry today announced its strategic partnership with Connance, a healthcare ... , The two companies’ proven, proprietary technology combine to provide health systems, ...
(Date:6/27/2016)... Park, KS (PRWEB) , ... June 27, 2016 , ... ... in retailers of Eyeglasses . , Millions of individuals in the United States ... eyeglasses have become a way to both correct vision and make a fashion statement. ...
(Date:6/26/2016)... Battle Creek, Michigan (PRWEB) , ... June 26, 2016 , ... ... abuse, joined as sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table ... held in honor of the city’s history as home to some of the world’s ...
(Date:6/26/2016)... ... ... PawPaws brand pet supplements owned by Whole Health Supply is ... of felines. The formula is all-natural and is made from Chinese herbs that have ... Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root Extract ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 ... appointment of Dr. Edward Futcher to ... Director, effective June 23, 2016.Dr. Futcher was also ... and Governance Committees.  As a non-executive member of ... expertise and strategic counsel to VolitionRx in connection ...
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... 52" report to their offering. ... creates a favourable commercial environment for MedImmune to enter. The ... that will serve to drive considerable growth for effective anti-influenza ... to cap sales considerably, but development is still in its ...
Breaking Medicine Technology: